The results indicate that etoposide as a single agent has only minimal activity in patients who have failed prior intensive chemotherapy and confirm the reports of other, recent, smaller studies in patients who had failed similar initial therapy. It is not uncommon for large multi-institutional studies to be less positive than studies in smaller numbers of patients at single institutions.
|Original language||English (US)|
|Number of pages||2|
|Journal||Cancer Treatment Reports|
|State||Published - Jul 31 1985|
ASJC Scopus subject areas
- Cancer Research